Codexis Inc. (CDXS)

Name: Codexis Inc. (CDXS) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Codexis Inc. (CDXS)

Stock Card

$1.59

$-0.07 (-4.22%)

As on 28-Aug-2026 16:00EDT

Market cap

$174 Mln

Revenue (TTM)

$78 Mln

P/E Ratio

P/B Ratio

5.5

Div. Yield

0 %

Codexis (CDXS) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.58 High: 1.68

52 Week Range

Low: 0.96 High: 2.98

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.7 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-10.7
Debt to Equity

0
Book Value

$0.4
EPS

$-0.3
Face value

--
Shares outstanding

109,505,765

10 Years Aggregate

CFO

$-110.32 Mln

EBITDA

$-168.41 Mln

Net Profit

$-236.14 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Codexis (CDXS)	-2.5	2.6	-39.8	-40.4	-1.2	-43.1	-9.3
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Codexis (CDXS)	-65.8	55.8	-34.5	-85.1	43.2	36.5	-4.3
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Codexis (CDXS)	1.6	174.1	77.7	-30.7	-37.8	-73.6	--	5.5
Arrowhead Pharmaceuticals (ARWR)	84.9	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Ascendis Pharma A/S - ADR	247.9	16,261.1	1,054.4	755.9	5.7	--	19	9.8
Cytokinetics Inc (CYTK)	72.1	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.5	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	105.4	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	351.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	533.8	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	600.7	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	344.8	9,625.4	0.0	-339.1	--	-30.6	--	7.6

Shareholding Pattern

View Details

About Codexis (CDXS)

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe,... the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California. Read more

President, CEO & Director

Dr. Stephen George Dilly MBBS, Ph.D.
President, CEO & Director

Dr. Stephen George Dilly MBBS, Ph.D.
Headquarters

Redwood City, CA
Website

https://www.codexis.com

FAQs for Codexis (CDXS)

What is the current share price of Codexis Inc (CDXS) Today?

The share price of Codexis Inc (CDXS) is $1.59 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Codexis Inc (CDXS) has given a return of -1.23% in the last 3 years.

What is the current PB & PE ratio of Codexis Inc (CDXS)?

Since, TTM earnings of Codexis Inc (CDXS) is negative, P/E ratio is not available.
The P/B ratio of Codexis Inc (CDXS) is 5.52 times as on 28-Aug-2026, a 7 premium to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.